Healthcare Business News
Joe Mullany, new DMC CEO

Detroit Medical Center CEO steps down to prepare for mayoral run, and other news

By Modern Healthcare
Posted: November 17, 2012 - 12:01 am ET


Mike Duggan, CEO of Detroit Medical Center, announced that he will step down from the for-profit health system to pave the way for a possible run for mayor of Detroit, Modern Healthcare sister publication Crain's Detroit Business reported. Joe Mullany, currently DMC president, will take over Duggan's duties Jan. 1. Mullany came to DMC this year from Massachusetts, where he ran Vanguard Health Systems' New England region; Vanguard owns DMC. Duggan has said he will make a final decision on whether to run for mayor by year-end.

Advertisement | View Media Kit


… Kettering Health Network, Dayton, Ohio, promoted Terri Day to president. Day, 52, has served as Kettering's executive VP of operations since November 2010. Fred Manchur, the system's former president and CEO, will continue with Kettering solely in the CEO role. Before joining Kettering, Day was VP of Adventist Health, Roseville, Calif. Day is the first woman to serve as Kettering's president. … Carondelet Health Network, Tucson, Ariz., promoted Dr. Amy Beiter to president and CEO of St. Mary's Hospital from chief medical officer at the hospital and promoted Tony Fonze to president and CEO of St. Joseph's Hospital from CIO of that hospital. Both hospitals are in Tucson. Beiter has served St. Mary's since 1992, since 2008 as CMO. Fonze formerly served as VP for Ascension Health Information Services. Carondelet also named several executives to positions at the system: Dr. Don Denmark as senior VP and CMO, Martha Gerganoff as a senior VP and chief nursing officer and Tawnya Tretschok as VP and executive director of physician practices. The executives' ages were not provided.

David Brooks, president, St. John, Detroit
… St. John Providence Health System, Warren, Mich., hired David Brooks as president of St. John Hospital and Medical Center in Detroit and senior VP of St. John Providence. Brooks, 51, is the former CEO of the Northwest Washington region of Providence Health & Services. Brooks will start his new job Feb. 11 and will replace Frank Poma, president of St. John River District Hospital in East China, Mich., who has served as St. John's interim leader since Diane Radloff retired in February. Radloff had held the post since 2008. St. John Providence is part of Ascension Health, St. Louis. … Lahey Health System, Burlington, Mass., which was formed after the merger of Northeast Health System, Beverly, Mass., and the Lahey Clinic, Burlington, earlier this year, said that Northeast Health System President and CEO Kenneth Hanover will step down. Denis Conroy, Lahey Health System's chief integration officer, will serve as interim president and CEO of Northeast, according to a news release. Conroy is the former executive VP and CFO at Northeast. Hanover—who will serve as executive VP and chief strategy officer for Lahey Health System through year-end—said in the release that “The time is right for me to step aside and afford Dr. Howard Grant the opportunity to move forward with a more integrated management structure.” Grant serves as president and CEO of the Lahey Health System and the Lahey Clinic.

Ed Hannah, chief nursing officer, Health First
… Integrated health system Health First, Rockledge, Fla., named Ed Hannah as its chief nursing officer. Hannah, 60, replaces Bonnie Rudolph, who is retiring after 24 years with the system. In addition to his role as CNO, Hannah will also serve as VP of patient-care services for Health First's Holmes Regional Medical Center, Melbourne, Fla. He steps into the role after serving as VP of patient-care services and quality and CNO at Boca Raton (Fla.) Regional Hospital. … Lakeland (Fla.) Regional Health Systems named Dr. J. Scott Swygert chief quality officer and chief medical information officer. Since 2007, Swygert has served as Lakeland Regional's medical director of hospitalist services, according to a Lakeland Regional news release. In 2011, he was appointed Lakeland Regional's chairman of medicine. Swygert will maintain his clinical duties in his new role. He joined the system as a hospitalist at Watson Clinic in 1996 and was “instrumental in Lakeland Regional's comprehensive electronic health-record implementation,” according to the release. His age was unavailable at deadline.


The TriZetto Group tapped Dr. Jeff Rose, former VP of clinical excellence and informatics for Ascension Health, to serve in the newly created position of chief medical information officer of the company's physician markets business unit. Rose, 59, will be charged with helping improve provider product offerings for the Denver-based health information technology vendor, according to a news release. Rose assumed his previous role at St. Louis-based Ascension Health in 2004 and has overseen health information exchange initiatives, health IT deployment and informatics-related programs for the system for eight years. Before that, he served as CMO of Cerner Corp. and CMO of Health Language. He was also named to Modern Healthcare's annual list of the Top 25 Clinical Informaticists in 2010 and 2011.


Bruce Broussard, president of Humana
Bruce Broussard, a former McKesson Corp. executive who was named president of Humana last year, will take over in January as CEO of the Louisville, Ky.-based insurer. Broussard, 50, will retain his role as president and succeed Humana CEO Michael McCallister, according to a news release. McCallister, 60, will remain chairman of the board. … Regence, a Portland, Ore.-based licensee of the Blue Cross and Blue Shield Association, named Dr. Richard Popiel senior VP of healthcare services and chief medical officer for all health insurance plans. Popiel, whose age wasn't provided, is the former president and COO at Horizon Healthcare Innovations, a division of Newark-based Blue Cross and Blue Shield of New Jersey. Popiel's responsibilities will include leading medical strategy and addressing care initiatives and cost management.


Sunrise Senior Living, McLean, Va., will undergo a leadership change after the company completes its acquisition by Health Care REIT. Mark Ordan, the company's CEO; Greg Neeb, its chief administrative and investment officer; and David Haddock, its general counsel, will step down from their roles after the sale, which is expected in 2013. Ordan will remain as CEO for up to a year during a transition period, according to a news release. He and Sunrise's founder and chairman, Paul Klaassen, will also serve on the company's board. Their ages were not available at deadline. Ordan joined the company in March 2008 as chief administrative and investment officer and stepped into the CEO role eight months later. Health Care REIT, Toledo, Ohio, entered into a definitive agreement to acquire the senior housing and assisted-living provider in August.


Michael Mahoney has assumed the role of president and CEO of Boston Scientific Corp., Natick, Mass., effective Nov. 1. He succeeds interim CEO Hank Kucheman. Mahoney, 47, was named president and CEO of Boston Scientific in September 2011, following the May 2011 announcement that Raymond Elliott would step down after less than two years as CEO. Mahoney assumed the role of president in October 2011, but because of noncompete obligations with his former employer, New Brunswick, N.J.-based Johnson & Johnson, it was more than a year before he was able to formally transition into the CEO post. Before joining Boston Scientific, Mahoney was worldwide chairman of Johnson & Johnson's medical devices and diagnostics group. Mahoney was also named to Boston Scientific's board of directors, taking a seat formerly occupied by Kucheman. Kucheman will stay on as an adviser and member of senior management until the end of the year, when he'll become a consultant to the company, according to a news release. … Teva Pharmaceutical Industries, a Jerusalem-based generic-drug manufacturer, named Allan Oberman president and CEO of the company's Teva Americas Generics. Oberman, 55, who most recently served as Teva's senior VP of North America generic pharmaceuticals, will continue to lead the North American generics business, as well as the Latin American business, according to a news release. He replaces William Marth, 58, who is serving as a senior adviser to Teva President and CEO Dr. Jeremy Levin until Marth retires at the end of next year. Levin was named president and CEO of Teva early this year.

What do you think?

Share your opinion. Send a letter to the Editor or Post a comment below.

Post a comment

Loading Comments Loading comments...



Switch to the new Modern Healthcare Daily News app

For the best experience of on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.